Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Mayo Clinic
The Christie NHS Foundation Trust
Dana-Farber Cancer Institute
Emory University
Institute of Oncology Ljubljana
Hasumi International Research Foundation
Institute of Oncology Ljubljana
Melanoma Institute Australia
H. Lee Moffitt Cancer Center and Research Institute
San Gallicano Dermatological Institute IRCCS
Institute of Oncology Ljubljana
Institute of Oncology Ljubljana
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
Wake Forest University Health Sciences
University of Wisconsin, Madison
Beth Israel Deaconess Medical Center
CHU de Reims
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Indiana University
Thomas Jefferson University
University Hospital, Tours
Swiss Cancer Institute
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Pittsburgh
OHSU Knight Cancer Institute
Abramson Cancer Center at Penn Medicine
Assistance Publique - Hôpitaux de Paris
Centre Hospitalier Universitaire de Nīmes
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Utah
Virginia Commonwealth University
University Hospital, Strasbourg, France
Centre Antoine Lacassagne
Abramson Cancer Center at Penn Medicine
Hospices Civils de Lyon
Hospices Civils de Lyon
Institut Curie
Assistance Publique - Hôpitaux de Paris
Mayo Clinic
Institut Cancerologie de l'Ouest
University Hospital, Grenoble